Notable Labs, Ltd. Ordinary Shares
NTBL
NTBL was delisted on the 22nd of October, 2024.
13 hedge funds and large institutions have $2.3M invested in Notable Labs, Ltd. Ordinary Shares in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 7 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
28% less capital invested
Capital invested by funds: $3.2M → $2.3M (-$895K)
35% less funds holding
Funds holding: 20 → 13 (-7)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$45.1K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$40.3K |
| 3 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$19.3K |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$12.6K |
| 5 |
Renaissance Technologies
New York
|
+$12.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$345K |
| 2 |
Millennium Management
New York
|
-$297K |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$59K |
| 4 |
Goldman Sachs
New York
|
-$25K |
| 5 |
Cerity Partners
New York
|
-$19K |
NTBL Hedge Fund Activity: Q3 2020 in Review
13 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Notable Labs, Ltd. Ordinary Shares (NTBL) for Q3 2020, worth a combined $2.3M — down 28% from $3.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of NTBL and 1 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Virtu Financial, adding an estimated $45.1K. The largest seller was Morgan Stanley, cutting an estimated $345K.
- 13 institutional investors held Notable Labs, Ltd. Ordinary Shares (NTBL) as of Q3 2020, down from 20 in Q2 2020.
- Funds reported $2.3M of Notable Labs, Ltd. Ordinary Shares stock for Q3 2020, down 28% quarter-over-quarter.
- 1 fund opened new Notable Labs, Ltd. Ordinary Shares positions in Q3 2020 and 7 closed out, a net change of -6 holders.
- The largest Notable Labs, Ltd. Ordinary Shares buyer in Q3 2020 was Virtu Financial, an estimated $45.1K added.
- The largest Notable Labs, Ltd. Ordinary Shares seller in Q3 2020 was Morgan Stanley, an estimated $345K sold.
Based on aggregated 13F filings for Q3 2020.